1. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1): 1-133.
|
2. |
Liu Y, Su L, Xiao H. Review of factors related to the thyroid cancer epidemic. Int J Endocrinol, 2017, 2017: 5308635.
|
3. |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin, 2018, 68(1): 7-30.
|
4. |
Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol), 2010, 22(6): 395-404.
|
5. |
Lloyd RV, Osamura RY, Kloppel G, et al. WHO classification of tumours of endocrine organs, Lyon, France: IARC, 2017: 1-20.
|
6. |
Mahajan S, Agarwal S, Kocheri N, et al. Cytopathology of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: a comparative study with similar patterned papillary thyroid carcinoma variants. Cytopathology, 2018, 29(3): 233-240.
|
7. |
Lloyd RV, Asa SL, LiVolsi VA, et al. The evolving diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Hum Pathol, 2018, 74: 1-4.
|
8. |
Hung YP, Barletta JA. A user’s guide to non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Histopathology, 2018, 72(1): 53-69.
|
9. |
Ward R. Carcinoma of the thyroid gland: a clinical and pathologic study of 293 patients at the University of California hospital. Calif Med, 1960, 93(4): 261.
|
10. |
Baloch ZW, Shafique K, Flannagan M, et al. Encapsulated classic and follicular variants of papillary thyroid carcinoma: comparative clinicopathologic study. Endocr Pract, 2010, 16(6): 952-959.
|
11. |
Vivero M, Kraft S, Barletta JA. Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid, 2013, 23(3): 273-279.
|
12. |
Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer, 2006, 107(6): 1255-1264.
|
13. |
Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg, 2014, 140(4): 317-322.
|
14. |
Howitt BE, Jia Y, Sholl LM, et al. Molecular alterations in partially-encapsulated or well-circumscribed follicular variant of papillary thyroid carcinoma. Thyroid, 2013, 23(10): 1256-1262.
|
15. |
Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol, 2016, 2(8): 1023-1029.
|
16. |
Jiang XS, Harrison GP, Datto MB. Young investigator challenge: molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Cancer Cytopathol, 2016, 124(12): 893-900.
|
17. |
Bizzarro T, Martini M, Capodimonti S, et al. Young investigator challenge: the morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: some insights into their identification. Cancer Cytopathol, 2016, 124(10): 699-710.
|
18. |
Paulson VA, Shivdasani P, Angell TE, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features accounts for more than half of " carcinomas” harboring RAS mutations. Thyroid, 2017, 27(4): 506-511.
|
19. |
Giannini R, Ugolini C, Poma AM, et al. Identification of two distinct molecular subtypes of non-invasive follicular neoplasm with papillary-like nuclear features by digital RNA counting. Thyroid, 2017, 27(10): 1267-1276.
|
20. |
Zhao L, Dias-Santagata D, Sadow PM, et al. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. Cancer Cytopathol, 2017, 125(5): 323-331.
|
21. |
Cho U, Mete O, Kim MH, et al. Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Mod Pathol, 2017, 30(6): 810-825.
|
22. |
Lee SE, Hwang TS, Choi YL, et al. Molecular profiling of papillary thyroid carcinoma in Korea with a high prevalence of BRAF thyroid. Thyroid, 2017, 27(6): 802-810.
|
23. |
Kim M, Jeon MJ, Oh HS, et al. BRAF and RAS mutational status in noninvasive follicular thyroid neoplasm with papillary-like nuclear features and invasive subtype of encapsulated follicular variant of papillary thyroid carcinoma in Korea. Thyroid, 2018, 28(4): 504-510.
|
24. |
Strickland KC, Eszlinger M, Paschke R, et al. Molecular testing of nodules with a suspicious or malignant cytologic diagnosis in the setting of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Endocr Pathol, 2018, 29(1): 68-74.
|
25. |
du Jour KP, Schmitt AC, Chen AY, et al. Application of strict criteria for noninvasive follicular thyroid neoplasm with papillary-like nuclear features and encapsulated follicular variant papillary thyroid carcinoma: a retrospective study of 50 tumors previously diagnosed as follicular vriant PTC. Endocr Pathol, 2018, 29(1): 35-42.
|
26. |
Wang Z, Wang W, Huang K, et al. MicroRNA-34a inhibits cells proliferation and invasion by downregulating Notch1 in endometrial cancer. Oncotarget, 2017, 8(67): 111258-111270.
|
27. |
Cui XB, Peng H, Li RR, et al. MicroRNA-34a functions as a tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh esophageal squamous cell carcinoma. Oncotarget, 2017, 8(54): 92454-92469.
|
28. |
Song L, Peng L, Hua S, et al. miR-144-5p enhances the radiosensitivity of non-small-cell lung cancer cells via targeting ATF2. Biomed Res Int, 2018, 2018: 5109497.
|
29. |
Chen K, Chen Y, Chen Z, et al. miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells. Onco Targets Ther, 2018, 11: 3141-3147.
|
30. |
Han L, Chen W, Xia Y, et al. MiR-101 inhibits the proliferation and metastasis of lung cancer by targeting zinc finger E-box binding homeobox 1. Am J Transl Res, 2018, 10(4): 1172-1183.
|
31. |
Sun W, Lan X, Wang Z, et al. MicroRNA-144 inhibits proliferation by targeting WW domain-containing transcription regulator protein 1 in papillary thyroid cancer. Oncol Lett, 2018, 15(1): 1007-1013.
|
32. |
Stefanescu H, Muntean D, Pilut C, et al. Using blood and plasma microRNAs as a non-invasive biomarker in patients with colorectal cancer. Clin Lab, 2018, 64(3): 257-262.
|
33. |
Xia D, Li X, Niu Q, et al. MicroRNA-185 suppresses pancreatic cell proliferation by targeting transcriptional coactivator with PDZ-binding motif in pancreatic cancer. Exp Ther Med, 2018, 15(1): 657-666.
|
34. |
Borrelli N, Denaro M, Ugolini C, et al. miRNA expression profiling of ‘noninvasive follicular thyroid neoplasms with papillary-like nuclear features’ compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas. Mod Pathol, 2017, 30(1): 39-51.
|
35. |
Jahanbani I, Al-Abdallah A, Ali RH, et al. Discriminatory miRNAs for the management of papillary thyroid carcinoma and noninvasive follicular thyroid neoplasms with papillary-like nuclear features. Thyroid, 2018, 28(3): 319-327.
|